| Literature DB >> 458941 |
P A Leblanc, S M Taffet, F A Fried, F P Avis.
Abstract
Sera from 27 patients with renal cancer, 14 patients with transitional cell carcinoma of the bladder and 21 normal controls were tested against 2 renal cancer lines (CAKI-1 and CAKI-2) by the iodinated protein A assay. All sera tested against CAKI-2 were absorbed first with AB+ substance because CAKI-2 was found to have cell surface A antigen. Sera from 16 of 27 patients with renal cell carcinoma, 3 of 14 patients with transitional cell carcinoma of the bladder and 2 of 21 normal controls were reactive with CAKI-1. Sera from 11 of 27 patients with renal cell carcinoma, 2 of 14 patients with transitional cell carcinoma of the bladder and 3 of 21 normal controls were reactive with CAKI-2. There is a positive correlation between the number of counts obtained by the renal patients' sera tested against CAKI-1 and CAKI-2.Entities:
Mesh:
Substances:
Year: 1979 PMID: 458941 DOI: 10.1016/s0022-5347(17)56970-0
Source DB: PubMed Journal: J Urol ISSN: 0022-5347 Impact factor: 7.450